Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7825027 | 0.85 | — | — | |
| SCHEMBL2654704 | 0.83 | DGAT1 (0.41) | SMN1; SMN2CA14KMT2ACA12CA1 | |
| SCHEMBL20657106 | 0.79 | — | — | |
| SCHEMBL1098657 | 0.78 | — | — | |
| SCHEMBL127462 | 0.78 | — | — | |
| SCHEMBL1097587 | 0.78 | — | — | |
| SCHEMBL16196001 | 0.78 | — | — | |
| SCHEMBL5664686 | 0.78 | — | — | |
| SCHEMBL344666 | 0.75 | — | — | |
| SCHEMBL7661704 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1725534-A1 | NOVEL AMIDO-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | Altana Pharma AG (DE) | 2006-11-29 | — | — | EP | claimed |
| WO-2005087745-A1 | NOVEL AMIDO-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-09-22 | — | — | WO | claimed |
| EP-0791016-A1 | POLYMER SYNTHESIS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| EP-4381345-A1 | SWITCHING LAYERS FOR USE IN A WINDOW ELEMENT | Merck Patent GmbH (DE) | 2024-06-12 | — | — | EP | disclosed |
| EP-3704176-B1 | ORGANIC SEMICONDUCTING COMPOUNDS | RAYNERGY TEK INC (TW) | 2024-05-15 | — | — | EP | disclosed |
| US-20240134218-A1 | DEVICE FOR THE REGULATION OF LIGHT TRANSMISSION | MERCK PATENT GMBH (DE) | 2024-04-25 | — | — | US | disclosed |
| US-11958819-B2 | Compounds for optically active devices | Johnson & Johnson Surgical Vision, Inc. (US) | 2024-04-16 | — | — | US | disclosed |
| US-11952528-B2 | Switching layers for use in a switching element | MERCK PATENT GMBH (DE) | 2024-04-09 | — | — | US | disclosed |
| EP-3794650-B1 | ORGANIC SEMICONDUCTORS | RAYNERGY TEK INC (TW) | 2024-03-13 | — | — | EP | disclosed |
| WO-2024012851-A1 | SUSTAINABLE ANTIOXIDANT COMPOSITION, USE THEREOF AND POLYMER COMPOSITION COMPRISING THE SAME | BASF SE (DE) | 2024-01-18 | — | — | WO | disclosed |
| US-11839155-B2 | Organic semiconducting compounds | RAYNERGY TEK INC. (TW) | 2023-12-05 | — | — | US | disclosed |
| EP-0381728-A1 | DIFLUOROMETHYL COMPOUNDS. | MERCK PATENT GMBH (DE) | 1990-08-16 | — | — | EP | disclosed |
| EP-0367771-A1 | ARYL SULPHUR PENTAFLUORIDES. | MERCK PATENT GMBH (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4925590-A | Derivatives of 4-cyano-2,3-difluorophenol | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-05-15 | — | — | US | disclosed |
| WO-1990001056-A1 | DIFLUOROMETHYL COMPOUNDS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-02-08 | — | — | WO | disclosed |
| WO-1989002425-A1 | FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1989-03-23 | — | — | WO | disclosed |
| WO-1988010251-A1 | ARYL SULPHUR PENTAFLUORIDES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1988-12-29 | — | — | WO | disclosed |
| US-4735959-A | HYPOGLYCEMIC AGENTS | DR. KARL THOMAE GMBH (DE) | 1988-04-05 | — | — | US | disclosed |
| EP-0099017-B1 | PHENYL-ACETIC-ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSTIONS CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1988-03-02 | — | — | EP | disclosed |
| EP-0099017-A2 | Phenyl-acetic-acid derivatives, their preparation and pharmaceutical compostions containing them | Dr. Karl Thomae GmbH (DE) | 1984-01-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11839155-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | SMN1; SMN2 3662/4885CA14 2127/4885ALDH1A1 2672/4885 |
| US-11958819-B2 | Compounds for optically active devices | PDE6C, ALDH1A2, PDE6A | SMN1; SMN2 4580/4885CA14 3995/4885ALDH1A1 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.